PlainRecalls
FDA Drug Low Class III Terminated

Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.

Reported: July 15, 2020 Initiated: June 23, 2020 #D-1377-2020

Product Description

Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.

Reason for Recall

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

Details

Recalling Firm
VistaPharm, Inc.
Units Affected
380,700 cups
Distribution
United States including Puerto Rico
Location
Largo, FL

Frequently Asked Questions

What product was recalled?
Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.. Recalled by VistaPharm, Inc.. Units affected: 380,700 cups.
Why was this product recalled?
Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 15, 2020. Severity: Low. Recall number: D-1377-2020.